학술논문
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma.
Document Type
journal article
Author
Fowler, Nathan H; Samaniego, Felipe; Jurczak, Wojciech; Ghosh, Nilanjan; Derenzini, Enrico; Reeves, James A; Knopińska-Posłuszny, Wanda; Cheah, Chan Y; Phillips, Tycel; Lech-Maranda, Ewa; Cheson, Bruce D; Caimi, Paolo F; Grosicki, Sebastian; Leslie, Lori A; Chavez, Julio C; Fonseca, Gustavo; Babu, Sunil; Hodson, Daniel J; Shao, Spencer H; Burke, John M
Source
Journal of Clinical Oncology; 5/20/2021, Vol. 39 Issue 15, p1609-1618, 10p
Subject
Language
ISSN
0732183X